Cargando…

SEVERE/REFRACTORY IMMUNE THROMBOCYTOPENIA IN MILD COVID-19 DISEASE

Detalles Bibliográficos
Autores principales:	MENON, TRISHALA, RICHARD, IRVIN, MARKS, EDWARD, SCHMITT, BRADLEY, MACHANI, SATHYANARAYANA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Chest Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503339/ http://dx.doi.org/10.1016/j.chest.2021.07.351

Ejemplares similares

An Unusual Presentation of a Patient With Low-Dose Methotrexate Causing Colitis and Pancytopenia
por: R, Ramya, et al.
Publicado: (2022)

SEVERE ALLERGIC ERYTHEMATOUS REACTION POSTMESSENGER RNA-BASED COVID-19 VACCINE
por: ALI, RUHMA, et al.
Publicado: (2022)

E. COLI PNEUMONIA WITH PNEUMATOCELE, EMPYEMA NECESSITANS, AND BRONCHOPLEURAL FISTULA IN A PATIENT WITH SEVERE COVID-19
por: Kahn, Michael, et al.
Publicado: (2020)

UNEXPECTED OPPORTUNISTIC INFECTION IN PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: NIEVES, HÉCTOR, et al.
Publicado: (2021)

ATYPICAL PAROTITIS AS A RESULT OF SEVERE COVID-19 INFECTION
por: MARCANO, ANDREW, et al.
Publicado: (2021)

SPECTRUM OF COVID-19 SEVERITY IN YOUNG ADULTS: A CASE SERIES
por: Riera, Maria Bernal, et al.
Publicado: (2020)

GIRAFFE IN THE COVID-19 LUNG: PULMONARY FIBROSIS LIMITING SEVERITY OF THE PNEUMOTHORAX
por: ALLEN CHAN, MARVYN, et al.
Publicado: (2021)

SEVERE COVID-19 PNEUMONIA IN A FULLY VACCINATED IMMUNOCOMPROMISED PATIENT
por: SUBRAMANIAN, LAKSHMI, et al.
Publicado: (2021)

CASE REPORT OF SEVERE PULMONARY FIBROSIS AS A SEQUELAE OF COVID-19 INFECTION
por: Arjun, Shiva, et al.
Publicado: (2020)

CATASTROPHIC STROKE DESPITE ASPIRIN AND THERAPEUTIC ENOXAPARIN IN PATIENT WITH SEVERE COVID-19
por: Condit, Daniel, et al.
Publicado: (2020)

THE SUBSEQUENT IMPACT OF COVID-19 FOR BOTH IMMUNE DYSREGULATION AND OPPORTUNISTIC INFECTIONS
por: SUH, CLARA, et al.
Publicado: (2022)

THE MULBSTA SCORE: PREDICTING RISK OF MORTALITY AND DISEASE SEVERITY IN PATIENTS WITH COVID-19 PNEUMONIA
por: Tusha, Jurgena, et al.
Publicado: (2020)

BLOOD TYPE AND MALE SEX AS POTENTIAL PREDICTORS OF SUSCEPTIBILITY, SEVERITY, AND OUTCOMES IN COVID-19
por: MA, EVA, et al.
Publicado: (2021)

POST-COVID-19 SYNDROME: CHARACTERIZATION OF A COHORT AND ASSOCIATION WITH ACUTE DISEASE SEVERITY
por: OLIVEIRA BAPTISTA DA SILVA, FERNANDA, et al.
Publicado: (2021)

PREVOTELLA BIVIA BACTEREMIA POST TOCILIZUMAB IN A PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: AIYANYOR, ALFRED, et al.
Publicado: (2021)

SINUS BRADYCARDIA AS A PREDICTOR OF SEVERITY OF COVID-19 INFECTION: TRANQUILITY BEFORE CHAOS
por: ARSALAN ZAIDI, SYED, et al.
Publicado: (2021)

PREDICTING COVID-19 SEVERITY USING A SIMPLE PARAMETERS IN RESOURCE-LIMITED SETTINGS
por: NIMITVILAI, S., et al.
Publicado: (2022)

FACTORS AFFECTING OUTCOMES IN PATIENTS WITH SEVERE COVID-19 WHO RECEIVED CONVALESCENT PLASMA THERAPY
por: SRIDEVI, T., et al.
Publicado: (2022)

IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AFTER USE OF ANTI-RETROVIRAL THERAPY IN COVID-19
por: NANGRANI, KUNAL, et al.
Publicado: (2021)

THE IMPACT OF COVID-19 VACCINATION ON DISEASE SEVERITY AND OUTCOMES IN HOSPITALIZED PATIENTS: A REAL-WORLD EXPERIENCE
por: SATISH, V., et al.
Publicado: (2022)

INADEQUATE IMMUNE RESPONSE TO COVID-19 VACCINES IN THE PRESENCE OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS)
por: KRISHNAIAH, AISHWARYA, et al.
Publicado: (2022)

COMPARISON OF SEVERITY AND CLINICAL OUTCOMES OF PATIENTS WITH COVID-19 FROM MULTIETHNIC BACKGROUNDS IN A TERTIARY CARE CENTER
por: SELVARAJ, J., et al.
Publicado: (2022)

TNF/IFN-GAMMA AXIS FAVORS SENESCENCE AND SEVERE INFLAMMATION ASSOCIATED WITH CELL DEATH IN PATIENTS WITH COVID-19
por: PALACIOS, Y., et al.
Publicado: (2022)

SEVERE PULMONARY BLASTOMYCOSIS IN A PATIENT WITH A COVID-19-POSITIVE TEST: A DANGEROUS ANCHORING BIAS
por: DURDEVIC, MOMCILO, et al.
Publicado: (2022)

SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ISOLATION FROM PLEURAL FLUID WITH COVID-19 PNEUMONIA AND SUPERIMPOSED EMPYEMA
por: Leys, Lorenzo, et al.
Publicado: (2020)

THE ROLE OF ASCORBIC ACID IN REDUCING MORTALITY IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: KHOKHER, WALEED, et al.
Publicado: (2021)

TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA
por: AHMED, MUBASHIR AYAZ, et al.
Publicado: (2022)

HEMOLYTIC ANEMIA EXACERBATION IN CHRONIC PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AFTER COVID-19 VACCINATION
por: YOU, JOSEPH, et al.
Publicado: (2022)

COVID-19 IN LUNG TRANSPLANT RECIPIENTS: A SINGLE CENTER EXPERIENCE
por: SATHIYAMOORTHY, GAYATHRI, et al.
Publicado: (2022)

D-DIMER AS A SURROGATE MARKER OF DISEASE SEVERITY IN AFRICAN AMERICAN POPULATION WITH COVID-19 PNEUMONIA: A COMMUNITY HOSPITAL RETROSPECTIVE STUDY
por: OMORE, IBRAHIM, et al.
Publicado: (2021)

ELDERLY PERSON WITH COVID-19 AND SEVERE ARDS WITH PROLONGED ACTIVE VIRAL REPLICATION AND DOUBLE RESURGENCE OF CYTOKINE STORM TREATED WITH SOTROVIMAB AND CASIRIVIMAB/IMDEVIMAB
por: SIRITHANAKUL, KASEM
Publicado: (2022)

INEQUITIES IN PHYSICAL DISTANCING PRACTICES IN THE US WORKPLACE DURING THE COVID-19 PANDEMIC
por: PAGUIO, JOSEPH ALEXANDER D, et al.
Publicado: (2022)

AN ISOLATED PLEURAL EFFUSION AS A SEQUELA OF COVID-19 INFECTION
por: Patel, Rutwik, et al.
Publicado: (2020)

BIO-MECHANICS OF ARDS IN COVID-19: A PROSPECTIVE OBSERVATIONAL STUDY
por: Naeem, Ehsun, et al.
Publicado: (2020)

INCIDENCE, CLINICAL CHARACTERISTICS, AND OUTCOMES OF PATIENTS WITH COVID-19 AND FUNGAL COINFECTION
por: SWANEY, RICHARD, et al.
Publicado: (2022)

PROTEINACEOUS COVID-19
por: Chandna, Sanya, et al.
Publicado: (2020)

SEVERE ADENOVIRUS PNEUMONIA IN RITUXIMAB INFUSIONS
por: BJORK, SARAH, et al.
Publicado: (2021)

Evolution of CT findings in patients with mild COVID-19 pneumonia
por: Liang, Ting, et al.
Publicado: (2020)

POST-COVID-19 ASPERGILLOSIS
por: BAIG, MARIA HAIDER
Publicado: (2022)

MACROGLOSSIA IN THE SETTING OF COVID-19
por: HASSANIN, ES-HAQ, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ji0nfhtprkv9trbl7jv8frb9h1